![](https://www.molecular-medicine-israel.co.il/wp-content/uploads/2018/02/fx1-2-300x300.jpg)
LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer
Highlights •LXR agonism reduces immunosuppressive MDSC levels in mice and cancer patients •LXR transcriptional target ApoE impairs MDSC survival •LXR-induced MDSC depletion enhances activation of